Skip to main navigation Skip to search Skip to main content

Budget impact and transferability of cost-effectiveness of DPYD testing in metastatic breast cancer in 3 health systems - supplementary material

  • Rositsa Koleva-Kolarova (Creator)
  • Heleen Vellekoop (Creator)
  • Simone Huygens (Creator)
  • Matthijs Versteegh (Creator)
  • Maureen van Molken (Contributor)
  • László Szilberhorn (Contributor)
  • Tamás Zelei (Contributor)
  • Balázs Nagy (Creator)
  • Sarah Wordsworth (Creator)
  • Apostolos Tsiachristas (University of Oxford, Oxford University Hospitals NHS Foundation Trust) (Creator)

Dataset

Description

Appendix Table 1. General (UK) model input parameters
Date made available2023
PublisherFuture Science Group

Access Dataset

Cite this